Interleukin-17 is a negative regulator of established allergic asthma. - Wikidata - awgldk - TriplyDB

Interleukin-17 is a negative regulator of established allergic asthma.

Interleukin-17 is a negative regulator of established allergic asthma.

http://www.wikidata.org/entity/Q36228146

about

IL-17RC: a partner in IL-17 signaling and beyond Mucosal-associated invariant T cells in autoimmunity, immune-mediated diseases and airways disease Th17-mediated inflammation in asthma Diversity of IL-17-producing T lymphocytes Treatment of allergic asthma: modulation of Th2 cells and their responses Innate lymphoid cells in the airways Endotoxin Exposure during Sensitization to Blomia tropicalis Allergens Shifts TH2 Immunity Towards a TH17-Mediated Airway Neutrophilic Inflammation: Role of TLR4 and TLR2 Allergen uptake, activation, and IL-23 production by pulmonary myeloid DCs drives airway hyperresponsiveness in asthma-susceptible mice Structure of the unique SEFIR domain from human interleukin 17 receptor A reveals a composite ligand-binding site containing a conserved α-helix for Act1 binding and IL-17 signaling Effect of IL-17 receptor A blockade with brodalumab in inflammatory diseases The IL-17 pathway as a major therapeutic target in autoimmune diseases Eosinophils in fungus-associated allergic pulmonary disease Enforced expression of GATA3 allows differentiation of IL-17-producing cells, but constrains Th17-mediated pathology RNA plasticity and selectivity applicable to therapeutics and novel biosensor development Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome Absence of alpha 4 but not beta 2 integrins restrains development of chronic allergic asthma using mouse genetic models Ovariectomized OVA-sensitized mice display increased frequency of CD4(+)Foxp3(+) T regulatory cells in the periphery Nod-like receptors: cytosolic watchdogs for immunity against pathogens.B cell antigen presentation promotes Th2 responses and immunopathology during chronic allergic lung disease In vivo disruption of TGF-beta signaling by Smad7 in airway epithelium alleviates allergic asthma but aggravates lung carcinogenesis in mouse.Development of allergen-induced airway inflammation in the absence of T-bet regulation is dependent on IL-17.Allogeneic splenocyte transfer and lipopolysaccharide inhalations induce differential T cell expansion and lung injury: a novel model of pulmonary graft-versus-host disease.Regulation of IL-9 expression by IL-25 signaling.Regulation of gastric B cell recruitment is dependent on IL-17 receptor A signaling in a model of chronic bacterial infection.Therapeutic potential of anti-interleukin-17A aptamer: suppression of interleukin-17A signaling and attenuation of autoimmunity in two mouse models.Elevation of IL-6 in the allergic asthmatic airway is independent of inflammation but associates with loss of central airway function Suppression of HIV-1 plasma viral load below detection preserves IL-17 producing T cells in HIV-1 infection.Particulate matter-induced airway hyperresponsiveness is lymphocyte dependent Activation of the mTOR signaling pathway is required for asthma onset.Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen Aligning mouse models of asthma to human endotypes of disease.Modulation of immunoglobulin production by invariant Vα19-Jα33 TCR-bearing cells.Interleukin-17 regulation: an attractive therapeutic approach for asthma Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13.IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease Importance of cytokines in murine allergic airway disease and human asthma.Role of Tyk-2 in Th9 and Th17 cells in allergic asthma.Control of Th2-mediated inflammation by regulatory T cells.Haemophilus influenzae infection drives IL-17-mediated neutrophilic allergic airways disease Peanut-induced intestinal allergy is mediated through a mast cell-IgE-FcepsilonRI-IL-13 pathway.

P2860

Q24629783-4FAF06DF-1962-41EA-8356-95D28FD9CEB4 Q26771558-B2C3ED80-0E8E-442D-B413-FF61A7AD99DC Q26861492-CF68C780-2492-4FDD-AAB0-D9B7BEA3D3F8 Q27010199-EF6A095D-E5B8-4C67-BF90-833B11D8C986 Q27011823-6EB2DE87-45EB-4AF2-B651-6704E09EA715 Q27012728-61060D2A-DCDF-429E-BA7F-7CE7FBD0EBA4 Q27312581-34CA5B10-1A20-4F7B-B422-05AF5974D904 Q27438135-550CF16E-FF0C-4FB3-BB7B-8E6061C7DB88 Q27683721-A5A3FDBD-ABAE-46BD-8874-2C4FB2F6B728 Q28076496-331BCD8C-7CAC-4CDA-B057-2C685C2F5914 Q28300826-ADAE95A5-CFF8-4D81-BF6C-7C95145F93EA Q28393919-8AA6E2EC-7447-437C-8AE9-BED18E127B67 Q28507698-D2DDAF1D-8FD8-4BB7-A7F1-22C227D5C897 Q28727743-F42ECFAB-1D90-4859-BA04-E47135E62749 Q29614595-8D460D92-9678-4B67-9276-252128BF8423 Q30540980-761D7DE0-9F07-4A78-B9B7-D27AAA284994 Q31120325-D3E43B12-EBA4-47CD-B541-07AB85B2103A Q33312855-9886E26C-00F9-4D03-87B3-DE31C3BAD56E Q33366487-0FDC0A57-D159-4AB1-9E0C-81E0BD136C9D Q33559861-D49D3494-9D65-4401-8372-5CC64EE0AC8E Q33611073-2992B102-3636-4ECA-8D67-A457D4A5CBF7 Q33638349-336EEC00-0915-4CF0-A523-D2BEED02776C Q33682703-045B6DB3-DEF0-401B-991C-FCA79817C270 Q33709574-A8A5CAC8-5C21-4EA0-A9FE-8E7224BB0B14 Q33725862-5A5579F0-B72F-43F4-A35C-F749B2EC7ECB Q33741676-55B7CAB6-5D73-4DC0-9682-93FC244D9931 Q33773625-E0AD8AC6-699F-433E-85A6-87D994A906D8 Q33837821-A970B6A2-9C66-4097-8948-6B25380F2531 Q33866861-DF1C806B-9261-4777-86BB-FCED8BBB5C92 Q33915290-B6AACA3C-D2DE-492D-A21F-B60656528994 Q33934140-86A6850B-765C-41A5-BF49-62F752CD0D59 Q33941005-EDBEAA88-C609-4711-A8DA-95F4806F2BE8 Q33951731-547CA387-E3BB-44BE-832C-E74A9D32B76C Q33954674-8BD8A617-C09F-4985-A38A-723FCBEEFBD4 Q33971114-BAADB7C1-3DA2-4F8C-AE06-39841EACED72 Q34003580-D266C7B6-CC1D-4698-B804-F2C960980EB5 Q34023371-D706FD00-D420-466D-A422-91DD31E47FC0 Q34033388-1E9BE86F-A6BE-429B-85E6-A0F5017BE577 Q34048095-BE8B6AD5-695E-45F0-AC8E-DE086EBDDBF8 Q34049963-A803CF5F-F654-452E-AF1F-BE0F63AFB2F2

P2860

Interleukin-17 is a negative regulator of established allergic asthma.

http://www.wikidata.org/entity/Q36228146

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Interleukin-17 is a negative regulator of established allergic asthma.

@ast

Interleukin-17 is a negative regulator of established allergic asthma.

@en

type

label

Interleukin-17 is a negative regulator of established allergic asthma.

@ast

Interleukin-17 is a negative regulator of established allergic asthma.

@en

prefLabel

Interleukin-17 is a negative regulator of established allergic asthma.

@ast

Interleukin-17 is a negative regulator of established allergic asthma.

@en

P1433

Q36228146-329BFDFC-CA49-4912-AC96-F4CF80113032

P1476

Q36228146-1D1C1544-BBCE-4D9A-9936-5DB784027E0B

P2093

Q36228146-2D09CAB5-4243-4D72-BDD1-6E615BB2D3E5

Q36228146-30095393-D0A2-4995-B460-E8BB8840FDC8

Q36228146-39E9DE65-E4A4-4B8D-AB07-C3844044C60D

Q36228146-F07D8685-69AB-4CCA-A240-4B412F61C373

P2860

Q36228146-0504B4B1-2967-4840-A2F8-50FEA3E3E125

Q36228146-0E18031D-89FF-4A77-8667-2C8CA4E8ECB6

Q36228146-15FF66AC-789D-4CA3-AE92-58E940C21F3C

Q36228146-1796B9F0-8173-47B1-8815-FC4328CBF168

Q36228146-199A6642-A561-41E4-B41E-602F374281E9

Q36228146-2651AD7E-6C17-4605-A6EA-4F64D6999EB3

Q36228146-29583856-EFFC-47EB-A6BA-E071995002BB

Q36228146-2B9F1938-6C2E-459D-AC2F-F23E30CB4E2F

Q36228146-2C84B321-CC95-4F17-8443-790C7F39D5FC

Q36228146-332F0070-83C3-4A14-9BB2-BCF4E46D5B7F

P304

Q36228146-8AA60B48-3D66-4AC4-B715-3DC80F01D8B5

P31

Q36228146-E881DF62-77CF-4791-8D6E-499DF8F61F53

P356

Q36228146-EA889ADB-95A2-4AB8-BBD6-B56DFB2EAF35

P407

Q36228146-D6C4958C-6161-49F4-832B-1433D2A56E85

P433

Q36228146-3E6CD238-4725-45C6-BE30-017AFAA69D8A

P478

Q36228146-F3A3387D-C3E8-4B7A-8749-742F6B4B9547

P50

Q36228146-85099326-B24B-4EFF-895E-8B9BDF2D12AE

Q36228146-893B0E10-12E8-4D51-877C-C98790F59806

Q36228146-C3464BD3-3C0C-4D58-A77F-A958E63BA0BB

Q36228146-E8EA2C58-E614-4837-BB1C-75EEC53241F0

Q36228146-F37FE6B6-AA01-4A32-BF57-F2E234DBE700

P577

Q36228146-B98536C2-586D-473C-BD1A-FEE7510AA191

P5875

Q36228146-A8847E19-8ADA-453A-9F49-68BDB8D981C9

P698

Q36228146-D0E034A1-00F5-4544-8DF4-E39E8BE57B04

P921

Q36228146-9E31F1A2-9137-4E68-A455-1A6A381B2ADE

P932

Q36228146-70C69B75-3E55-4594-98F6-341F3D69A286

P356

P1433

Journal of Experimental Medicine

P1476

Interleukin-17 is a negative regulator of established allergic asthma.

@en

P2093

Bruno Schnyder

http://www.w3.org/2001/XMLSchema#string

Francois Fossiez

http://www.w3.org/2001/XMLSchema#string

Frank Brombacher

http://www.w3.org/2001/XMLSchema#string

Isabelle Mercier

http://www.w3.org/2001/XMLSchema#string

P2860

Human IL-17: a novel cytokine derived from T cells

Interleukin-17 family and IL-17 receptors

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection.

P304

2715-2725

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20061401

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

203

http://www.w3.org/2001/XMLSchema#string

P50

Bernhard Ryffel

Isabelle Couillin

Valérie Quesniaux

Silvia Schnyder-Candrian

Dieudonnée Togbe

P577

2006-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6695366

http://www.w3.org/2001/XMLSchema#string

P698

17101734

http://www.w3.org/2001/XMLSchema#string

P921

P932

2118159

http://www.w3.org/2001/XMLSchema#string